当前位置:首页 - 行情中心 - 迈威生物-U(688062) - 财务分析 - 现金流量表

迈威生物-U

(688062)

  

流通市值:116.70亿  总市值:228.41亿
流通股本:2.04亿   总股本:4.00亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金484,917,067.4355,090,410.77222,438,243.27180,722,393.45
  收到的税费返还--1,001,103.89-
  收到其他与经营活动有关的现金69,865,618.884,291,650.04141,624,254.02118,419,345.9
  经营活动现金流入小计554,782,686.3159,382,060.81365,063,601.18299,141,739.35
  购买商品、接受劳务支付的现金6,782,481.151,576,538.6729,069,018.521,922,867.5
  支付给职工以及为职工支付的现金259,378,037.61109,071,015.94468,090,653.05365,179,181.34
  支付的各项税费10,936,683.636,362,782.4421,977,121.1918,699,340.99
  支付其他与经营活动有关的现金311,609,944.55158,988,464.93802,370,438.62561,561,140.58
  经营活动现金流出小计588,707,146.94275,998,801.981,321,507,231.36967,362,530.41
  经营活动产生的现金流量净额-33,924,460.63-216,616,741.17-956,443,630.18-668,220,791.06
二、投资活动产生的现金流量:
  收回投资收到的现金41,873,582.1831,873,582.18382,459,886.99319,656,518.58
  取得投资收益收到的现金302,196.27282,196.272,987,529.872,402,898.44
  投资活动现金流入小计42,175,778.4532,155,778.45385,447,416.86322,059,417.02
  购建固定资产、无形资产和其他长期资产支付的现金87,210,321.3235,441,639.18330,068,047.25226,460,591.16
  投资支付的现金42,630,877.6642,387,334.98346,933,530.18290,908,037.57
  取得子公司及其他营业单位支付的现金12,560,621.089,304,163.76-7,863,248.66
  投资活动现金流出小计142,401,820.0687,133,137.92677,001,577.43525,231,877.39
  投资活动产生的现金流量净额-100,226,041.61-54,977,359.47-291,554,160.57-203,172,460.37
三、筹资活动产生的现金流量:
  吸收投资收到的现金200,000,000---
  其中:子公司吸收少数股东投资收到的现金200,000,000---
  取得借款收到的现金867,140,000651,840,0003,605,480,873.492,239,740,873.49
  收到其他与筹资活动有关的现金100,000,000100,000,0002,892,417.22,892,417.2
  筹资活动现金流入小计1,167,140,000751,840,0003,608,373,290.692,242,633,290.69
  偿还债务支付的现金792,468,562.31533,172,555.632,669,130,225.011,343,537,169.38
  分配股利、利润或偿付利息支付的现金41,051,813.423,155,253.166,111,902.5244,771,259.36
  支付其他与筹资活动有关的现金38,255,764.4414,379,662.2941,433,330.9427,190,464.53
  筹资活动现金流出小计871,776,140.15570,707,471.022,776,675,458.471,415,498,893.27
  筹资活动产生的现金流量净额295,363,859.85181,132,528.98831,697,832.22827,134,397.42
四、汇率变动对现金及现金等价物的影响-153,575.87-138,837.15232,889-933,514.53
五、现金及现金等价物净增加额161,059,781.74-90,600,408.81-416,067,069.53-45,192,368.54
  加:期初现金及现金等价物余额1,227,566,165.231,227,566,165.231,643,633,234.761,643,633,234.76
  期末现金及现金等价物余额1,388,625,946.971,136,965,756.421,227,566,165.231,598,440,866.22
补充资料:
  净利润-552,229,971.82--1,046,564,705.48-
  资产减值准备7,689,770.12-5,526,750.78-
  固定资产和投资性房地产折旧88,831,754.32-93,556,473.38-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧88,831,754.32-93,556,473.38-
  无形资产摊销3,950,097.2-18,800,120.51-
  长期待摊费用摊销683,533.49-1,503,622.62-
  递延收益摊销307,233.33-16,481,698.53-
  固定资产报废损失--113,812.15-
  公允价值变动损失-18,138.89--493,457.59-
  财务费用39,669,599.2-58,526,661.97-
  投资损失2,865,785.93-4,218,903.47-
  递延所得税0-0-
  其中:递延所得税资产减少3,242,372.45-6,845,605.13-
    递延所得税负债增加-3,242,372.45--6,845,605.13-
  存货的减少-6,847,580.81--57,909,335.94-
  经营性应收项目的减少-13,076,265.95--77,362,611.67-
  经营性应付项目的增加381,297,671.28--36,242,173.54-
  现金的期末余额1,388,625,946.97-1,191,693,931.96-
  减:现金的期初余额1,191,693,931.96-1,643,633,234.76-
  加:现金等价物的期末余额--35,872,233.27-
  减:现金等价物的期初余额35,872,233.27---
  现金及现金等价物的净增加额161,059,781.74--416,067,069.53-
公告日期2025-08-302025-04-292025-03-312024-10-31
审计意见(境内)标准无保留意见
TOP↑